Matsuo H, Nakamura N, Tomizawa D, Saito AM, Kiyokawa N, Horibe K, Nishinaka-Arai Y, Tokumasu M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S
Pediatric blood & cancer 63(8) 1394-1399 Aug 2016 [Refereed]
Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.
Tokumasu M, Murata C, Shimada A, Ohki K, Hayashi Y, Saito AM, Fujimoto J, Horibe K, Nagao M, Itoh H, Kamikubo Y, Nakayama H, Kinoshita A, Tomizawa D, Taga T, Tawa A, Tanaka S, Heike T, Adachi S.
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Shiba N, Ohki K, Hayashi Y, Yamashita Y, Shimada A, Tanaka S, Adachi S
Haematologica 99(11) e225-7 Nov 2014 [Refereed]
Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.
Matsuo H, Kajihara M, Tomizawa D, Watanabe T, Saito AM, Fujimoto J, Horibe K, Kodama K, Tokumasu M, Itoh H, Nakayama H, Kinoshita A, Taga T, Tawa A, Taki T, Tanaka S, Adachi S.
H. Chin; T. Saito; A. Arai; K. Yamamoto; R. Kamiyama; N. Miyasaka; O. Miura
Biochemical and Biophysical Research Communications 239(2) 412-417 Oct 1997 [Refereed]
Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor β subunit (β(IL3)) and recruitment of Stat5 to possible Stat5- docking sites in β(IL3)
H. Chin; H. Wakao; A. Miyajima; R. Kamiyama; N. Miyasaka; O. Miura